Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study

por Rejdak, Konrad, Zasybska, Adriana, Pietruczuk, Aleksandra, Baranowski, Dariusz, Szklener, Sebastian, Kaczmarek, Magda, Stelmasiak, Zbigniew
Publicado 2021